![Surviving-an-FDA-GCP-Inspection-500.jpg Surviving an FDA GCP Inspection](https://www.centerwatch.com/ext/resources/products/Surviving-an-FDA-GCP-Inspection-500.jpg?height=200&t=1605810958&width=200)
Home » IP Shakti launches PipeLinX for open innovation
IP Shakti launches PipeLinX for open innovation
July 3, 2013
IP Shakti, an early stage biomedical fund, has launched PipeLinX, a new concept in open innovation solutions. The PipeLinX service sorts through university technology to focus on emerging technologies in the field.
PipeLinX utilizes university technology and intellectual property opportunities. According to the AUTM Licensing Survey (FY2011), universities in the U.S. spent about $61.4 billion on research leading to 21,800 inventions and 19,900 new patent applications. PipeLinX considers the entire U.S. university system, not just the top universities, before narrowing down the number of technologies.
PipeLinX Reports were created to present due diligence information in a format that meets industry standards. Industry scientists, patent attorneys and early stage entrepreneurs provide comprehensive coverage of a technology's strengths and weaknesses. The proprietary scoring system allows for a comparison between technologies and across fields of use. Reports are created that review, compare and rank technologies based on patent, market and technological strengths. Some of the metrics used in the scoring system include the regulatory landscape, attractiveness for licensing and comparable deals.
Upcoming Events
-
21Oct